Home/ Supplements/ Omega 3/ Super Omega 3 EPA 300 / DHA 200 Formula

Super Omega 3 EPA 300 / DHA 200 Formula

product on market Softgel Capsule 3T Federal Solutions Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Super Omega 3 EPA 300 / DHA 200 Formula
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
100
Servings
Fat/Fatty Acid
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
10 Calorie(s)
Total Fat
1 Gram(s) (2% DV)
Fish Body Oil
1000 mg

Other Ingredients

Gelatin Glycerin Vitamin E
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take as directed by physician.

Warnings & Precautions

Warning: Pregnant or lactating women should consult with their physician prior to using this dietary supplement.

Keep out of the reach of children.

Contains: Fish (mackerel, sardines, anchovy) ingredients.

Formulation Notes

Cold water, deep sea, fish oil

Purified to eliminate mercury

Contains: Fish (mackerel, sardines, anchovy) ingredients.

Additional Information

Store at 15-30(0)C (59-86(0)F) Protect from heat, light and moisture.

3T QualiTy ReliabiliTy IntegriTy

EFA Essential Fatty Acids

Made in the USA

NSF Quality Assurance International

Metadata

Product Details

UPC / SKU50682011901
DSLD Entry Date2019-08-23
Product TypeFat/Fatty Acid
FormSoftgel Capsule
DSLD ID206064
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.